Lead Product(s) : Sirolimus
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Timber Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe.
Product Name : Pascomer
Product Type : Antibiotic
Upfront Cash : Undisclosed
March 17, 2021
Lead Product(s) : Sirolimus
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Timber Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement